|
Guidelines
to Set up a Nuclear Medicine Facility
In
Nuclear Medicine (NM), the diagnostic and therapeutic procedures
using unsealed radioisotopes shall be carried out only in a facility
approved by the Atomic Energy Regulatory Board (AERB). The approved
nuclear medicine facility should not be located in the residential
building and shall comply with all the regulatory requirements as
specified in the AERB safety code on nuclear medicine facilities
AERB/RF-MED/SC-2(Rev.2),2011.
All the application forms pertaining to nuclear medicine facility
which are required to be submitted during various stages for its
approval are available at www.aerb.gov.in.
The various stages of approval of nuclear medicine facility by AERB
are given as follows:
1. Site and
Layout Plan Approval
2. Application for Authorization for Commissioning of the Facility
3. Pre-commissioning Inspection.
4. Approval for Commissioning / Routine Operation.
5. Decommissioning.
For
full guidelines, click here
Guidelines
to Set up a Medical Cyclotron Facility
A
new era of Nuclear Medicine diagnosis has started with Medical Cyclotron
technology. Medical Cyclotron produces mainly positron emitters,
which can be used in molecular imaging of the organs. In Medical
Cyclotron, particles such as protons, deuterons are accelerated
and made to bombard to a suitable target material to produce positron-emitting
radioisotopes. The positron emitters are produced by the (p,a),
(p, n) or (d, n) reaction. The neutron activation of the surrounding
medium draws the major attention in radiation safety. The medical
cyclotrons are mainly classified as self-shielded or non self-shielded
one. The self-shielded medical cyclotrons are incorporated with
heavy shielding around the cyclotron. Additional structural shielding
needs to be provided for non self-shielded medical cyclotron to
reduce the radiation levels to within safe limits.
A chemical synthesis module is necessary to prepare radiopharmaceutical
from the positron emitting radioisotopes produced in medical cyclotron.
The accelerated particles may lead to activation of materials around
the target and leave residual radioactivity. Although, the radioactive
isotopes produced due to neutron activation are generally of short
half-lives, their accumulated activity should be considered while
handling the shielding materials, parti cularly the components near
to the target that are likely to get activated to significant levels.
For
full guidelines, click here
|
